American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 4 , Pages 244-249 , July 2009

Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation

  • Joshua D. Lawson, MD

      Affiliations

    • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
    • ,
  • Jennifer Gaultney, MPH

      Affiliations

    • Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA, USA
    • ,
  • Nabil Saba, MD

      Affiliations

    • Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    • ,
  • William Grist, MD

      Affiliations

    • Department of Otolaryngology/Head and Neck Surgery, Emory University School of Medicine, Atlanta, GA, USA
    • ,
  • Lawrence Davis, MD, FACR

      Affiliations

    • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
    • ,
  • Peter A.S. Johnstone, MD, FACR

      Affiliations

    • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
    • Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    • Corresponding Author InformationCorresponding author. Radiation Oncology Department, Emory University School of Medicine, 1365 Clifton Rd NE, Atlanta, GA 30322, USA. Tel.: +1 404 778 3473; fax: +1 404 778 4139.

Received 6 April 2008

References 

  1. American Cancer Society. Cancer Facts and Figures. Atlanta: American Cancer Society; 2007;
  2. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  3. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16:1310–1317
  4. Calais G, Bardet E, Sire C, et al. Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. Int J Radiat Oncol Biol Phys. 2004;58:161–166
  5. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69–76
  6. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098
  7. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003;21:631–637
  8. Murry T, Madasu R, Martin A, et al. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck. 1998;20:31–37
  9. Kotz T, Costello R, Li Y, et al. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck. 2004;26:365–372
  10. Logemann JA, Rademaker AW, Pauloski BR, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck. 2006;28:64–73
  11. Newman LA, Vieira F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124:589–592
  12. Liu SA, Tsai WC, Wong YK, et al. Nutritional factors and survival of patients with oral cancer. Head Neck. 2006;28:998–1007
  13. Ravasco P, Monteiro-Grillo I, Marques Vidal P, et al. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005;27:659–668
  14. Gauderer M. Twenty years of percutaneous endoscopic gastrostomy: origin and evolution of a concept and its expanded applications. Gastrointest Endosc. 1999;50:879–883
  15. Gauderer MW, Ponsky JL, Izant RJ. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872–875
  16. Fay DE, Poplausky M, Gruber M, et al. Long-term enteral feeding: a retrospective comparison of delivery via percutaneous endoscopic gastrostomy and nasoenteric tubes. Am J Gastroenterol. 1991;86:1604–1609
  17. Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care (Engl). 1997;6:45–49
  18. Hujala K, Sipila J, Pulkkinen J, et al. Early percutaneous endoscopic gastrostomy nutrition in head and neck cancer patients. Acta Otolaryngol. 2004;124:847–850
  19. Anwander T, Berge S, Appel T, et al. Percutaneous endoscopic gastrostomy for long-term feeding of patients with oropharyngeal tumors. Nutr Cancer. 2004;50:40–45
  20. Crary MA, Groher ME. Reinstituting oral feeding in tube-fed adult patients with dysphagia. Nutr Clin Pract. 2006;21:576–586
  21. Ahmed KA, Samant S, Vieira F. Gastrostomy tubes in patients with advanced head and neck cancer. Laryngoscope. 2005;115:44–47
  22. Gardine RL, Kokal WA, Beatty JD, et al. Predicting the need for prolonged enteral supplementation in the patient with head and neck cancer. Am J Surg. 1988;156:63–65
  23. Mangar S, Slevin N, Mais K, et al. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol. 2006;78:152–158
  24. Schweinfurth JM, Boger GN, Feustel PJ. Preoperative risk assessment for gastrostomy tube placement in head and neck cancer patients. Head Neck. 2001;23:376–382
  25. Amdur RJ, Li JG, Liu C, et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck. 2004;26:257–263[discussion 263-4]
  26. Dabaja B, Salehpour MR, Rosen I, et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys. 2005;63:1000–1005
  27. Rosenthal DI, McDonough J, Kassaee A. The effect of independent collimator misalignment on the dosimetry of abutted half-beam blocked fields for the treatment of head and neck cancer. Radiother Oncol. 1998;49:273–278
  28. Duan J, Shen S, Spencer SA, et al. A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT. Int J Radiat Oncol Biol Phys. 2004;60:959–972
  29. Fua TF, Corry J, Milner AD, et al. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys. 2007;60:976–981
  30. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys. 2004;60:1425–1439
  31. Lawson JD, Otto K, Grist W, Johnstone PAS. Increased frequency of esophageal stenosis following simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol. 2008;29:13–19

☆ Dr Johnstone is a Georgia Cancer Coalition Distinguished Cancer Scholar, supported in part by the Georgia Cancer Coalition.

PII: S0196-0709(08)00111-7

doi: 10.1016/j.amjoto.2008.06.010

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 4 , Pages 244-249 , July 2009

Article Tools

* Image Usage & Resolution